AzTrials
AzTrials

Diabetes Mellitus (Type 1 and Type 2)NCT07591103

Socio-Ecological Determinants and Health Literacy: A Path Analysis of Self-Management Agency Among Patients With Diabetes Mellitus

An observational study of Diabetes Mellitus (Type 1 and Type 2), run by Alexandria University at 2 sites in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to examine the relationships between socio-ecological determinants, health literacy, and self-management agency among patients with diabetes mellitus. Using a path analysis framework, the study investigates how multi-level socio-ecological factors and different dimensions of health literacy influence… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Diabetes Mellitus (Type 1 and Type 2)
What is being tested?
Questionnaire-based assessment
How many people
400 participants
Where
2 sitesEgypt
Study dates
15 May 2026to 30 Jul 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients diagnosed with type 1 or type 2 diabetes mellitus and attending outpatient clinics or primary healthcare centers.

Who may be able to join

  • - Adults aged 18 years and older.
  • Diagnosed with type 1 or type 2 diabetes mellitus.
  • Receiving follow-up care in outpatient or primary healthcare settings.
  • Able to communicate verbally and provide informed consent.

Who cannot join

  • - Patients with severe cognitive impairment.
  • Patients with acute medical conditions preventing participation.
  • Pregnant women diagnosed with gestational diabetes.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Mohamed Fakhry Ahmed Salem, phd contact

+201286038014

Mohamed.Fakhry@alexu.edu.eg

Ahmed Salem contact

Mohamed.Fakhry@alexu.edu.eg

Egypt2 sites, 2 recruiting
  • Alexandria University Hospital, Faculty of Nursing

    Alexandria, Alexandria Governorate, 21511

    Mohamed Fakhry Ahmed Salem, PhD Medical-Surgical Nursing, 01286038014, Mohamed.Fakhry@alexu.edu.eg

    Mohamed Fakhry Ahmed Salem, PhD in Medical-Surgical Nursin

    Recruiting
  • Faculty of Nursing, Alexandria University

    Alexandria, Alexandria Governorate, 21511

    Mohamed Fakhry Ahmed Salem, phd, 01286038014, Mohamed.Fakhry@alexu.edu.eg

    Mohamed Fakhry Ahmed Salem, PhD in Medical-Surgical Nursin

    Not yet recruiting

Other trials in Egypt

About this study

Official title: Socio-Ecological Determinants and Health Literacy as Predictors of Self-Management Agency Among Patients With Diabetes Mellitus: A Cross-Sectional Path Analysis Study

This study aims to examine the relationships between socio-ecological determinants, health literacy, and self-management agency among patients with diabetes mellitus. Using a path analysis framework, the study investigates how multi-level socio-ecological factors and different dimensions of health literacy influence patients' capacity for diabetes self-management. Understanding these pathways will support the development of comprehensive, context-sensitive interventions to improve diabetes outcomes.

Read the detailed description

Diabetes mellitus is a chronic condition requiring sustained self-management behaviors influenced by individual capacities, social support systems, healthcare structures, community resources, and health policies. This observational study adopts the Social Ecological Model and Orem's Self-Care Deficit Theory to evaluate the combined effects of socio-ecological determinants and health literacy on self-management agency.

Data will be collected using structured questionnaires, including adapted health literacy and self-care agency scales, along with researcher-developed instruments assessing socio-demographic variables and socio-ecological determinants. Path analysis will be employed to examine direct and indirect relationships among study variables.

Being tested
Questionnaire-based assessment
Keywords
Diabetes Mellitus, Health Literacy, Self-Management, Socio-Ecological Determinants, Self-Care Agency
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire-based assessmentOther

    No clinical or behavioral intervention is applied. This observational study involves a questionnaire-based assessment to collect data on socio-ecological determinants, health literacy, and self-management agency among adult patients with diabetes mellitus.

Study groups in NCT07591103
Study groupRoleWhat they receive
Patients with Diabetes MellitusAdult patients diagnosed with type 1 or type 2 diabetes mellitus receiving outpatient follow-up care and participating in a cross-sectional observational assessment.
Receives: Other: Questionnaire-based assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-management agency

    The level of self-management agency among adult patients with diabetes mellitus, measured using the adapted Appraisal of Self-Care Agency Scale-Revised (ASAS-R).

    Measured: Baseline (cross-sectional assessment)

Secondary outcomes (2)
  1. Health literacy

    Health literacy levels measured using the adapted All Aspects of Health Literacy Scale (AAHLS), including functional, communicative, and critical domains.

    Measured: At enrollment

  2. Socio-ecological determinants of diabetes self-management

    Socio-ecological determinants measured across individual, interpersonal, organizational, community, and policy levels using a researcher-developed assessment tool.

    Measured: At enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 May 2026
  2. Study start15 May 2026
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion30 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07591103
Sponsor's protocol ID
AU-20-10-463
Status last verified
May 2026
First submitted
7 May 2026
Last updated
5 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Diabetes Mellitus (Type 1 and Type 2), run by Alexandria University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Fakhry Ahmed Salem, phd (+201286038014, Mohamed.Fakhry@alexu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-management agency (time frame: Baseline (cross-sectional assessment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in